Adrenal disease

“A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

Adverse effects to synacthen are rare. Pretest morning cortisol is a reliable predictor for SST outcome and is a helpful tool to rationalise use of the SST. Predictive morning-cortisol thresholds vary according to the aetiology of AI.

Study context

Population
All patients referred for short-synacthen test (SST) in Oxford, 2017–2021, for suspected adrenal insufficiency (AI); males 38%, age 52 [39–66] yearsSSTs performed
Participants
1,480 patients
Exposure
Group 1 vs Group 2 vs Group 3
  • Group 1n = 505
  • Group 2n = 838
  • Group 3n = 137
Outcome
Pretest predictors of SST outcome ("SST pass") and adverse event profile of the SST
Methodological detailssingle-centre, tertiary care centre
  • Single-centre
  • Tertiary care centre

Main finding

As reported in the abstract

Predictors of SST pass; pretest morning cortisol threshold predicting SST pass with 100% specificity
GroupValueROC AUC95% CIPSpecificity
Group 1≥300 nmol/L0.7630.675 to 0.850p < 0.001100%
Group 2≥340 nmol/L0.6880.615 to 0.761p < 0.001100%
Group 3≥376 nmol/L0.7830.708 to 0.859p < 0.001100%

Value

Group 1≥300 nmol/L
Group 2≥340 nmol/L
Group 3≥376 nmol/L

ROC AUC

Group 10.763
Group 20.688
Group 30.783

95% CI

Group 10.675 to 0.850
Group 20.615 to 0.761
Group 30.708 to 0.859

P

Group 1p < 0.001
Group 2p < 0.001
Group 3p < 0.001

Specificity

Group 1100%
Group 2100%
Group 3100%
Whole cohort: B for morning cortisol
B = 0.015, p < 0.001
Group 1: B for morning cortisol
B = 0.018, p < .001
Group 2: B for morning cortisol
B = 0.010, p < 0.012
Group 3: B for morning cortisol
B = 0.018, p = <.001
Whole cohort: morning cortisol threshold ≥343 nmol/l predicting SST pass with 100% specificity; ROC AUC
0.725, p < 0.001 (95% CI 0.675-0.775)

Observational data: associations, not effects.

Safety

Adverse effects of SST

Tests with adverse effects recorded
1.8%
Anaphylaxis
1 episode

Original publication

“A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience. Clin Endocrinol (Oxf). Published 8 June 2023. doi:10.1111/cen.14934

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.